Use of NK-1 receptor antagonists in pruritus
US8906951B1 · kind B1 · utility
16Cited by
13References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2013 |
| Grant date | Dec 9, 2014 |
| Priority date | — |
| Expiry date | Jun 24, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods for treating pruritus with an NK-1 receptor antagonist. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.